Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer

Randomized phase II trial targeting early-stage breast cancer (stage II-III) applicable to preoperative chemotherapy (NAC), comparing standard treatment with multiple experimental treatments.

Trial Details

NCT ID

NCT06535893

Phase

PHASE2

Sponsor

Nagoya City University

Status

RECRUITING

Cancer Type

Breast Cancer

Interventions

TN
TN-1

Locations (sample)

Nagoya, Aichi-ken, Japan|35.18147,136.90641

Key Eligibility Criteria

Histologically or cytologically confirmed invasive breast carcinoma
Stage II or III
ECOG performance status of 0 or 1

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →